NT_1170x120_1-11-18

CVS Health Research Institute

CVS: Interventions yield savings with chronic patients

CVS: Interventions yield savings with chronic patients

WOONSOCKET, R.I. — Interventions that keep chronic disease patients on their medications are “extraordinarily cost-effective,” according to CVS Health. CVS said Monday that a new study from the CVS Health Research Institute, published in The American Journal of Managed Care, also found a greater opportunity for savings if medication adherence resources focus on patients with

CVS Specialty Connect elevates adherence

WOONSOCKET, R.I. — New research published by the CVS Health Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health’s specialty prescription services program. New patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and existing

CVS Specialty Connect sees improved Rx adherence

CVS Specialty Connect sees improved Rx adherence

WOONSOCKET, R.I. — CVS Health found that patients in a pilot study of its Specialty Connect specialty drug program had a significant improvement in adherence to their medication. CVS said Friday that new patients enrolled in the pilot were 17.5% more likely to pick up their first refill, and current specialty patients had an 11.4

Study: Narrow networks can raise adherence rates

WOONSOCKET, R.I. — A CVS Health Research Institute review of pharmacy claims for more than 200,000 patients found an association between narrow pharmacy networks and improved medication ­adherence. The study was the first to evaluate the impact of narrow pharmacy networks — which incentivize plan members to use in-network pharmacies — on medication adherence. Such

CVS Health: Initial Rx fills offer adherence clues

CVS Health: Initial Rx fills offer adherence clues

WOONSOCKET, R.I. — The first prescriptions filled by patients with chronic conditions provide a good sign of how well they will adhere to their medications, according to research by CVS Health. CVS said Monday that a new study by the CVS Health Research Institute and Brigham and Women’s Hospital revealed that patients’ patterns of medication

Research shows impact of CVS’ decision to exit tobacco

WOONSOCKET, R.I. — Cigarette purchases across the retail spectrum have declined measurably in the year since CVS/pharmacy banned tobacco sales, CVS Health reported this month. “One year ago, we stopped selling tobacco products because it conflicted with our purpose of helping people on their path to better health,” said CVS Health chief medical officer Dr.

CVS study: Narrow networks aid Rx adherence

CVS study: Narrow networks aid Rx adherence

WOONSOCKET, R.I. — Members of drug benefit plans with narrow pharmacy networks show improved medication adherence, according to a new study by the CVS Health Research Institute. CVS Health said Tuesday that the research, published in JAMA Internal Medicine, is the first to gauge the impact of narrow pharmacy networks on medication adherence. Narrow networks

CVS makes strides in cutting tobacco use

CVS makes strides in cutting tobacco use

WOONSOCKET, R.I. — CVS/pharmacy’s removal of tobacco products from its stores is showing its impact a year later. A study by the CVS Health Research Institute revealed a reduction in cigarette purchases over the past year, CVS Health said Thursday. Evaluating cigarette pack purchases at drug, food, big-box, dollar, convenience and gas station retailers in the

CVS researchers re-examine cholesterol treatments

WOONSOCKET, R.I. — CVS Health Research Institute experts have urged cardiologists to consider changing their treatment guidelines for patients with high cholesterol as a new class of high-cost medications arrives on the market. A commentary published online in the Journal of the American Medical Association on August 10 argued that the new cholesterol-lowering drugs, known

CVS Health: Rx therapy for high cholesterol needs review

CVS Health: Rx therapy for high cholesterol needs review

WOONSOCKET, R.I. — The cardiology community should review and reconsider current treatment guidelines for the management of high cholesterol, according to experts at the CVS Health Research Institute. In a commentary published online Monday in the Journal of the American Medical Association (JAMA), the CVS Health experts said that as PCSK9 inhibitors — a new

CVS to offer employees incentives to quit smoking

CVS to offer employees incentives to quit smoking

WOONSOCKET, R.I. — Next month, CVS Health plans to launch an employee smoking cessation program that reflects the findings of new research and continues the company’s efforts to reduce tobacco use. According to a study by the CVS Health Research Institute and researchers from the University of Pennsylvania’s Perelman School of Medicine, employer-sponsored smoking cessation programs that offer financial incentives show higher